{Boc}-Phe-Leu-Phe-Leu-Phe (TFA)

• UNSPSC Description:

  {Boc}-Phe-Leu-Phe-Leu-Phe TFA is a formyl peptide receptor (FPR) family antagonist that preferentially inhibits activity triggered through the formyl peptide receptor[1].

• Target Antigen:

  Formyl Peptide Receptor (FPR)

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/boc-phe-leu-phe-leu-phe-tfa.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(O)[C@H](CC1=CC=CC=C1)NC([C@@H](CC(C)C)NC([C@H](CC2=CC=CC=C2)NC([C@@H](CC(C)C)NC([C@H](CC3=CC=CC=C3)NC(OC(C)(C)C)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O

• Molecular Weight:

  899.99

• References & Citations:

  [1]Anna-Lena Stenfeldt, et al. Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation. 2007 Dec;30(6):224-9.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported